Facebook Pixel Code

Goldline Pharmaceutical Share Price

NSE
BSE

GOLDLINE PHARMACEUTICAL

Smallcap | BSE

Here's the live share price of Goldline Pharmaceutical along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹47.28 Closed
-3.41₹ -1.67
As on Jun 11, 2026, 04:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Source: Dion Global

Goldline Pharmaceutical Price Performance

Today's LowToday's High
₹45.00₹49.93
₹47.28
52 Weeks' Low52 Weeks' High
₹41.76₹60.00
₹47.28
Open Price
₹48.95
Prev. Close
₹48.95
Volume
2,13,000

Source: Dion Global

Goldline Pharmaceutical Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Goldline Pharmaceutical
10.06-16.72-16.72-16.72-16.72-5.92-3.59
Sun Pharmaceutical Industries
1.09-3.93-1.43-0.456.3522.2221.43
Divi's Laboratories
1.18-0.635.083.73-0.6924.749.01
Torrent Pharmaceuticals
5.811.563.6220.7543.1736.3826.09
Cipla
-1.066.003.99-8.54-9.1312.957.40
Zydus Lifesciences
1.8615.5819.9219.8612.9729.4310.70
Dr. Reddy's Laboratories
0.63-0.36-3.810.16-5.5910.903.18
Lupin
1.171.31-3.019.3612.2040.5713.08
Mankind Pharma
1.17-3.536.189.940.1617.3310.84
Aurobindo Pharma
-0.06-1.5612.1124.7526.0730.157.68
Laurus Labs
-2.409.9833.9236.82105.8459.4517.90
Biocon
0.176.635.329.1317.5320.300.07
Alkem Laboratories
0.47-5.31-4.22-5.768.4816.5610.65
Glenmark Pharmaceuticals
-1.57-8.63-5.519.7631.2549.8226.90
Abbott India
0.76-6.29-4.34-7.79-17.695.849.78
Anthem Biosciences
4.62-0.5120.2913.866.802.221.32
Ipca Laboratories
0.105.765.8310.3016.7230.439.65
Ajanta Pharma
6.622.543.2018.5718.7129.8419.16
Gland Pharma
3.8120.0738.4236.1937.1134.09-6.05
J B Chemicals & Pharmaceuticals
6.442.776.8025.0932.1428.5024.12

Source: Dion Global

Over the last one year, Goldline Pharmaceutical has declined 16.72% compared to peers like Sun Pharmaceutical Industries (6.35%), Divi's Laboratories (-0.69%), Torrent Pharmaceuticals (43.17%). From a 5 year perspective, Goldline Pharmaceutical has underperformed peers relative to Sun Pharmaceutical Industries (21.43%) and Divi's Laboratories (9.01%).

Goldline Pharmaceutical Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Source: Dion Global

Goldline Pharmaceutical Stock Technicals

Moving Average

DaySMAEMA
543.744.08
1044.745.51
2035.20
5014.080
1007.040
2003.520

Source: Dion Global

Goldline Pharmaceutical Share Holding Pattern

Goldline Pharmaceutical Corporate Actions

Date Time
Announcement
Jun 10, 2026, 12:37 AM IST ISTGoldline Pharma. - Announcement under Regulation 30 (LODR)-Change in Management
Jun 10, 2026, 12:30 AM IST ISTGoldline Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026
Jun 10, 2026, 12:25 AM IST ISTGoldline Pharma. - Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026
Jun 02, 2026, 09:31 PM IST ISTGoldline Pharma. - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligati
May 19, 2026, 01:35 PM IST ISTGoldline Pharma. - Listing of Equity Shares of Goldline Pharmaceutical Ltd

Source: Dion Global

About Goldline Pharmaceutical

Goldline Pharmaceutical Ltd. is a Public Limited Listed company incorporated on 02/08/2004 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U51397MH2004PLC147806 and registration number is 147806. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 28.06 Cr. and Equity Capital is Rs. 6.90 Cr. for the Year ended 31/03/2025.

Source: Dion Global

Management

  • Mr. Amol Laxmikant Mujumdar
    Chairman & Managing Director
  • Mr. Swapan Premprakash Khandelwal
    Whole Time Director
  • Mr. Prashant Shrikrishna Karkare
    Executive Director
  • Mr. Avinash Pandurang Ambulkar
    Executive Director
  • Mr. Prashant Vithalrao Rahate
    Non Executive Director
  • Mr. Mehul Hari Ranade
    Independent Director
  • Ms. Renuka Saurabh Borole
    Independent Director
  • Ms. Shraddha Kiran Kulkarni
    Addnl.Independent Director

FAQs on Goldline Pharmaceutical Share Price

What is the share price of Goldline Pharmaceutical?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Goldline Pharmaceutical is ₹47.28 as on Jun 11, 2026.

What kind of stock is Goldline Pharmaceutical?

The Goldline Pharmaceutical is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Goldline Pharmaceutical?

The market cap of Goldline Pharmaceutical is ₹45.39 Cr as on Jun 11, 2026.

What are today's High and Low prices of Goldline Pharmaceutical?

Today’s highest and lowest price of Goldline Pharmaceutical are ₹49.93 and ₹45.00.

What are the 52 Week High and 52 Week Low of Goldline Pharmaceutical?

The 52-week high/low is the highest and lowest price at which Goldline Pharmaceutical stock has traded in the past 52-week or nearly a year. The 52-week high of Goldline Pharmaceutical is ₹60.00 and 52-week low of Goldline Pharmaceutical is ₹41.76 as on Jun 11, 2026.

How has the Goldline Pharmaceutical performed historically in terms of returns?

The Goldline Pharmaceutical has shown returns of -3.41% over the past day, -16.72% for the past month, -16.72% over 3 months, -16.72% over 1 year, -5.92% across 3 years, and -3.59% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Goldline Pharmaceutical?

P/E ratio of and PB ratio of Goldline Pharmaceutical are 11.03 and 3.43 on Jun 11, 2026. While the company gives a dividend yield of 0.00 per annum.

Source: Dion Global

Goldline Pharmaceutical News